The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study ...
Jan 15, 2020
0
1
As concerns over vaping continue to grow, researchers and public health officials are investigating the causes of more than 40 deaths and 2,000 illnesses. It's confusing even for experts.
Nov 29, 2019
0
4
Despite restrictions on paid advertising cannabis on social media, most teenagers reported seeing marijuana marketing on Facebook, Twitter and Instagram, according to a public health study authored by University of Massachusetts ...
Nov 22, 2019
5
1
Eonsmoke LLC has been ordered to halt illegal sales of 100 unapproved flavored vaping products in the United States, the U.S. Food and Drug Administration says.
Oct 25, 2019
0
1
The health care market is failing to support new antibiotics used to treat some of the world's most dangerous, drug-resistant "superbugs," according to a new analysis by University of Pittsburgh School of Medicine infectious ...
Oct 7, 2019
0
5
Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's ...
Jul 30, 2019
0
4
Most consumers haven't shopped around for standard medical procedures such as a knee replacement, but reference pricing could open that possibility for many services and lower health care costs at the same time.
Jul 15, 2019
0
2
Australians have access to mass amounts of potent drugs online, equivalent to "billions of doses" every day, according to a new study from the Australian National University (ANU).
Apr 12, 2019
0
3
Anyone keeping tabs on how much they spend at the pharmacy knows that drug costs are rising, but what exactly is driving prices upward is often a mystery.
Jan 11, 2019
0
1
Healthcare spending in the United States is the highest in the world: totaling $3.3 trillion—or 17.8% of the GDP—in 2016. To capture market share—and to expand the market—drug companies and healthcare organizations ...
Jan 8, 2019
2
15
